|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mlynarsky L, Menachem Y and Shibolet O:
Treatment of hepatocellular carcinoma: Steps forward but still a
long way to go. World J Hepatol. 7:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang ZY: Hepatocellular carcinoma - cause,
treatment and metastasis. World J Gastroenterol. 7:445–454. 2001.
View Article : Google Scholar
|
|
4
|
Herranz H and Cohen SM: MicroRNAs and gene
regulatory networks: Managing the impact of noise in biological
systems. Genes Dev. 24:1339–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arner P and Kulyté A: MicroRNA regulatory
networks in human adipose tissue and obesity. Nat Rev Endocrinol.
11:276–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang S, Deng Y, Gu P and Fan X: MicroRNAs
regulate bone development and regeneration. Int J Mol Sci.
16:8227–8253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Su Y, Wu H, Pavlosky A, Zou LL, Deng X,
Zhang ZX and Jevnikar AM: Regulatory non-coding RNA: New
instruments in the orchestration of cell death. Cell Death Dis.
7:e23332016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tran DDH, Kessler C, Niehus SE, Mahnkopf
M, Koch A and Tamura T: Myc target gene, long intergenic noncoding
RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and
cell survival by titrating tumor suppressor microRNAs. Oncogene.
37:75–85. 2018. View Article : Google Scholar
|
|
10
|
Allegra A, Alonci A, Campo S, Penna G,
Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New
biomarkers in diagnosis, prognosis and treatment of cancer
(Review). Int J Oncol. 41:1897–1912. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kunej T, Godnic I, Ferdin J, Horvat S,
Dovc P and Calin GA: Epigenetic regulation of microRNAs in cancer:
An integrated review of literature. Mutat Res. 717:77–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
13
|
Mizuguchi Y, Takizawa T, Yoshida H and
Uchida E: Dysregulated miRNA in progression of hepatocellular
carcinoma: A systematic review. Hepatol Res. 46:391–406. 2016.
View Article : Google Scholar
|
|
14
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krützfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with 'antagomirs'. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Afonso MB, Rodrigues PM, Simão AL, Gaspar
MM, Carvalho T, Borralho P, Bañales JM, Castro RE and Rodrigues
CMP: miRNA-21 ablation protects against liver injury and
necroptosis in cholestasis. Cell Death Differ. Dec 11–2017.Epub
ahead of print. PubMed/NCBI
|
|
17
|
Qin D, Wang X, Li Y, Yang L, Wang R, Peng
J, Essandoh K, Mu X, Peng T, Han Q, et al: MicroRNA-223-5p and -3p
cooperatively suppress necroptosis in ischemic/reperfused hearts. J
Biol Chem. 291:20247–20259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen D, Yu J and Zhang L: Necroptosis: An
alternative cell death program defending against cancer. Biochim
Biophys Acta. 1865:228–236. 2016.PubMed/NCBI
|
|
19
|
Wang T, Jin Y, Yang W, Zhang L, Jin X, Liu
X, He Y and Li X: Necroptosis in cancer: An angel or a demon?
Tumour Biol. 39:1010428317711539. 2017. View Article : Google Scholar
|
|
20
|
Sutterwala FS, Haasken S and Cassel SL:
Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci.
1319:82–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davis BK, Wen H and Ting JP: The
inflammasome NLRs in immunity, inflammation, and associated
diseases. Annu Rev Immunol. 29:707–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X,
Zhao W, Huai W, Guo P and Han L: Deregulation of the NLRP3
inflammasome in hepatic parenchymal cells during liver cancer
progression. Lab Invest. 94:52–62. 2014. View Article : Google Scholar
|
|
23
|
Gurung P, Anand PK, Malireddi RK, Vande
Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR,
Lamkanfi M and Kanneganti TD: FADD and caspase-8 mediate priming
and activation of the canonical and noncanonical Nlrp3
inflammasomes. J Immunol. 192:1835–1846. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weng D, Marty-Roix R, Ganesan S, Proulx
MK, Vladimer GI, Kaiser WJ, Mocarski ES, Pouliot K, Chan FK,
Kelliher MA, et al: Caspase-8 and RIP kinases regulate
bacteria-induced innate immune responses and cell death. Proc Natl
Acad Sci USA. 111:7391–7396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gurung P and Kanneganti TD: Novel roles
for caspase-8 in IL-1β and inflammasome regulation. Am J Pathol.
185:17–25. 2015. View Article : Google Scholar :
|
|
26
|
Kang TB, Yang SH, Toth B, Kovalenko A and
Wallach D: Caspase-8 blocks kinase RIPK3-mediated activation of the
NLRP3 inflammasome. Immunity. 38:27–40. 2013. View Article : Google Scholar
|
|
27
|
Xie XJ, Ma LG, Xi K, Fan DM, Li JG, Zhang
Q and Zhang W: Effects of microRNA-223 on morphine analgesic
tolerance by targeting NLRP3 in a rat model of neuropathic pain.
Mol Pain. 13:1744806917706582. 2017. View Article : Google Scholar
|
|
28
|
Neudecker V, Haneklaus M, Jensen O,
Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS,
Gerich ME, et al: Myeloid-derived miR-223 regulates intestinal
inflammation via repression of the NLRP3 inflammasome. J Exp Med.
214:1737–1752. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Z, Zhong L, Xian R and Yuan B:
MicroRNA-223 regulates inflammation and brain injury via feedback
to NLRP3 inflammasome after intracerebral hemorrhage. Mol Immunol.
65:267–276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bauernfeind F, Rieger A, Schildberg FA,
Knolle PA, Schmid-Burgk JL and Hornung V: NLRP3 inflammasome
activity is negatively controlled by miR-223. J Immunol.
189:4175–4181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haneklaus M, Gerlic M, Kurowska-Stolarska
M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O'Neill LA and
Masters SL: Cutting edge: miR-223 and EBV miR-BART15 regulate the
NLRP3 inflammasome and IL-1β production. J Immunol. 189:3795–3799.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Venza M, Visalli M, Biondo C, Oteri R,
Agliano F, Morabito S, Teti D and Venza I: Epigenetic marks
responsible for cadmiuminduced melanoma cell overgrowth. Toxicol In
Vitro. 29:242–250. 2015. View Article : Google Scholar
|
|
34
|
Vilaysane A, Chun J, Seamone ME, Wang W,
Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, et al: The
NLRP3 inflammasome promotes renal inflammation and contributes to
CKD. J Am Soc Nephrol. 21:1732–1744. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−∆ ∆ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
36
|
Vlachos IS, Kostoulas N, Vergoulis T,
Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD,
Prionidis K, Dalamagas T and Hatzigeorgiou AG: DIANA miRPath v.2.0:
Investigating the combinatorial effect of microRNAs in pathways.
Nucleic Acids Res. 40W:W498–W504. 2012. View Article : Google Scholar
|
|
37
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38(Suppl 2): W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song J, Bai Z, Han W, Zhang J, Meng H, Bi
J, Ma X, Han S and Zhang Z: Identification of suitable reference
genes for qPCR analysis of serum microRNA in gastric cancer
patients. Dig Dis Sci. 57:897–904. 2012. View Article : Google Scholar
|
|
40
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M,
et al: Combinatorial microRNA target predictions. Nat Genet.
37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti
N, Castanares M and Wu M: Cleavage of RIP3 inactivates its
caspase-independent apoptosis pathway by removal of kinase domain.
Cell Signal. 19:2056–2067. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Günther C, Martini E, Wittkopf N, Amann K,
Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath
MF, et al: Caspase-8 regulates TNF-α-induced epithelial necroptosis
and terminal ileitis. Nature. 477:335–339. 2011. View Article : Google Scholar
|
|
43
|
Oberst A, Dillon CP, Weinlich R, McCormick
LL, Fitzgerald P, Pop C, Hakem R, Salvesen GS and Green DR:
Catalytic activity of the caspase-8-FLIP(L) complex inhibits
RIPK3-dependent necrosis. Nature. 471:363–367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vucur M, Reisinger F, Gautheron J, Janssen
J, Roderburg C, Cardenas DV, Kreggenwinkel K, Koppe C, Hammerich L,
Hakem R, et al: RIP3 inhibits inflammatory hepatocarcinogenesis but
promotes cholestasis by controlling caspase-8- and JNK-dependent
compensatory cell proliferation. Cell Reports. 4:776–790. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang K, Liu F, Zhou LY, Ding SL, Long B,
Liu CY, Sun T, Fan YY, Sun L and Li PF: miR-874 regulates
myocardial necrosis by targeting caspase-8. Cell Death Dis.
4:e7092013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chan FK, Shisler J, Bixby JG, Felices M,
Zheng L, Appel M, Orenstein J, Moss B and Lenardo MJ: A role for
tumor necrosis factor receptor-2 and receptor-interacting protein
in programmed necrosis and antiviral responses. J Biol Chem.
278:51613–51621. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo
J and Hu X: Shikonin circumvents cancer drug resistance by
induction of a necroptotic death. Mol Cancer Ther. 6:1641–1649.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Newton K and Manning G: Necroptosis and
Inflammation. Annu Rev Biochem. 85:743–763. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Long JS and Ryan KM: New frontiers in
promoting tumour cell death: Targeting apoptosis, necroptosis and
autophagy. Oncogene. 31:5045–5060. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou W and Yuan J: Necroptosis in health
and diseases. Semin Cell Dev Biol. 35:14–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu X, Zhou M, Mei L, Ruan J, Hu Q, Peng
J, Su H, Liao H, Liu S, Liu W, et al: Key roles of necroptotic
factors in promoting tumor growth. Oncotarget. 7:22219–22233.
2016.PubMed/NCBI
|
|
52
|
Seifert L, Werba G, Tiwari S, Giao Ly NN,
Alothman S, Alqunaibit D, Avanzi A, Barilla R, Daley D, Greco SH,
et al: The necrosome promotes pancreatic oncogenesis via CXCL1 and
Mincle-induced immune suppression. Nature. 532:245–249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Strilic B, Yang L, Albarrán-Juárez J,
Wachsmuth L, Han K, Müller UC, Pasparakis M and Offermanns S:
Tumour-cell-induced endothelial cell necroptosis via death receptor
6 promotes metastasis. Nature. 536:215–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pasparakis M and Vandenabeele P:
Necroptosis and its role in inflammation. Nature. 517:311–320.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Korniluk A, Koper O, Kemona H and
Dymicka-Piekarska V: From inflammation to cancer. Ir J Med Sci.
186:57–62. 2017. View Article : Google Scholar :
|
|
57
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Geserick P, Hupe M, Moulin M, Wong WW,
Feoktistova M, Kellert B, Gollnick H, Silke J and Leverkus M:
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting
RIP1 kinase recruitment. J Cell Biol. 187:1037–1054. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Welz PS, Wullaert A, Vlantis K, Kondylis
V, Fernández-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van
Loo G and Pasparakis M: FADD prevents RIP3-mediated epithelial cell
necrosis and chronic intestinal inflammation. Nature. 477:330–334.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hitomi J, Christofferson DE, Ng A, Yao J,
Degterev A, Xavier RJ and Yuan J: Identification of a molecular
signaling network that regulates a cellular necrotic cell death
pathway. Cell. 135:1311–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Stelzer Y, Sagi I and Benvenisty N:
Involvement of parental imprinting in the antisense regulation of
onco-miR-372-373. Nat Commun. 4:27242013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
He D, Miao H, Xu Y, Xiong L, Wang Y, Xiang
H, Zhang H and Zhang Z: MiR-371-5p facilitates pancreatic cancer
cell proliferation and decreases patient survival. PLoS One.
9:e1129302014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhai F, Cao C, Zhang L and Zhang J:
miR-543 promotes colorectal cancer proliferation and metastasis by
targeting KLF4. Oncotarget. 8:59246–59256. 2017. View Article : Google Scholar : PubMed/NCBI
|
